Dwelling-based most cancers care startup Reimagine Care scored $25 million in a Collection A funding spherical led by Santé Ventures, Martin Ventures and LRVHealth.
Different buyers taking part embrace the CU Healthcare Innovation Fund, Metropolis of Hope, McKesson Ventures and Sable Investments.
WHAT IT DOES
The corporate companions with suppliers and well being plans to coordinate care within the house to keep away from pointless inpatient visits.
Reimagine clinicians can remotely monitor sufferers, work with oncologists to find out whether or not sufferers want further companies and ship house care staff to help if wanted.
WHAT IT’S FOR
Reimagine plans to make use of the capital to enhance and commercialize its platform, launch a digital care heart and rent new members for its care workforce.
“We’re honored to accomplice with these skilled monetary and strategic buyers who share our perception that the time is now to maneuver away from the established order method of delivering most cancers care, which hasn’t tailored to a digital, digital world and transfer in the direction of offering a greater expertise for the hundreds of thousands of sufferers who cope with this horrible illness annually,” cofounder and CEO Dr. Aaron Gerber stated in a press release.
“We’re desirous to speed up the commercialization of our tech-enabled companies platform to assist well being techniques to offer high-quality, home-centered care, improve profitability and improve the affected person expertise, whereas additionally differentiating themselves from opponents who fail to take this vital leap ahead.”
The COVID-19 pandemic accelerated the usage of telehealth and at-home care, with an HHS report discovering Medicare visits carried out through telehealth elevated sixty-three-fold throughout the pandemic, from roughly 840,000 in 2019 to 52.7 million in 2020.
Firms are hoping they’ll push higher-level care into the house as properly. Final yr, Israeli firm Biobeat launched a take-home version of its distant affected person monitoring platform, together with a steady vitals monitor, affected person app and a cloud-based affected person administration system.
In 2020, Swedish oncology remedy tech firm Elekta introduced it could acquire Kaiku Health, which permits sufferers to trace their signs and alert their care workforce with updates. The Kaiku service launched in the U.S. late final yr.
Distant monitoring and analytics firm Biofourmis additionally moved into the most cancers area in 2020 with its purchase of Takeda Pharmaceuticals’ Gaido Health, a digital software that makes use of distant monitoring, affected person surveys and analytics to watch sufferers at house.